Genenta Science SpA ADR (GNTA) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $0.96
• Market Cap: $22.24M
• EPS: $-0.56
• 52-Week High: $6.20
• 52-Week Low: $0.70

Market Sentiment

Genenta Science SpA ADR currently has a Neutral sentiment score of 0.14.

About Genenta Science SpA ADR

Genenta Science SpA (GNTA) is a clinical-stage biotechnology company headquartered in Milan, Italy, specializing in hematopoietic stem cell gene therapies for solid tumor treatment. By employing advanced genetic engineering techniques, Genenta is at the forefront of developing innovative cancer therapies that aim to significantly transform existing treatment paradigms. With a strong pipeline of product candidates and strategic partnerships, the company is strategically positioned to meet urge...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Genenta Science SpA ADR and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does GNTA pay dividends?

Genenta Science SpA ADR (GNTA) does not currently pay a regular dividend.

What is GNTA's market cap?

Genenta Science SpA ADR (GNTA) has a market capitalization of $22.24M with a current stock price of $0.96.